Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Alliance of Grifols & Shanghai RAAS in China Gets Approval (2019-11-13)
> The operation is expected to close before the end of 2019, after the necessary approvals have been received from the regulatory authorities in the United States and the People’s Republic of China > Grifols will control a 26.2% stake in Shanghai RAAS (economi...
Bavarian Nordic Appoints Jean-Christophe May as CCO (2019-11-13)
Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced the appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer, effective from January 2020. In this role, Mr. May will lead the establishment of the Bavarian Nordic co...
Drug Discovery s/w Company Turbine Secures €3 Seed Funding (2019-11-13)
> Simulation-first approach provides deeper understanding of cancer cells, and supports rational decision-making to unlock new treatments > Company’s first institutional funding will be used to expand workflow across all phases of drug discovery Turbine, a...
CEO Marc Funk to Leave for Personal Reasons (2019-11-12)
Lonza announced today that Marc Funk, CEO, will leave the Company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on the additional responsibility of Chief Executive Officer on an ad interim basis until a permanen...
Merck Licenses CRISPR Gene-Editing Technology to Evotec (2019-11-12)
License to accelerate research, enable testing and development of new drugs Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property....
Kiadis Terminates ATIR101, Restructures & Lays Off 50% (2019-11-12)
> Kiadis will focus all future investments on developing off-the-shelf and haplo donor NK-cell therapies for the treatment of solid and liquid tumors > Discontinues development of ATIR101, stopping phase 3 trial > Restructures organization; reducing workforce...
Vaximm & NEC Partner for Personalised Cancer Vaccines (2019-11-12)
> Clinical trial collaboration agreement leverages NEC’s cutting-edge AI technology and VAXIMM’s novel oral T-cell immunotherapy technology > NEC to make an equity investment in VAXIMM NEC Corporation (NEC; TSE: 6701), a leader in IT and network technologie...
[iito] Launches Transatlantic Life Sciences Business Portal (2019-11-11)
> [LSUS] Life-Sciences-USA.com Launches Today > Over 50,000 Hand-edited Pages Available for Free > Focus on News Involving Players from Europe & North America > No Content Marketing, No Personalised Tracking & No Mailings > New Demo Version of Asian Lif...
eGenesis $100m Series B Round Led by Fresenius MCV (2019-11-07)
– Financing led by Fresenius Medical Care Ventures – Proceeds will be used to accelerate lead program in kidney xenotransplant into the clinic and progress a range of other xenotransplant programs across solid organ and cell therapy eGenesis, a biotechnolog...
Artios Pharma In-licenes DNA Damage Response Inhibitor (2019-11-06)
Artios Pharma Limited (Artios), The University of Texas MD Anderson Cancer Center (MD Anderson) and ShangPharma Innovation (ShangPharma) today announce the in-licensing by Artios of a small-molecule ATR inhibitor programme, developed jointly by MD Anderson and Shan...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top